Sarepta Therapeutics
SRPT
SRPT
134 hedge funds and large institutions have $1.28B invested in Sarepta Therapeutics in 2013 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
5% more funds holding
Funds holding: 128 → 134 (+6)
30% less call options, than puts
Call options by funds: $175M | Put options by funds: $250M
Holders
134
Holding in Top 10
5
Calls
$175M
Puts
$250M
Top Buyers
| 1 | +$43M | |
| 2 | +$26.1M | |
| 3 | +$25.7M | |
| 4 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$23.6M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$23.6M |
Top Sellers
| 1 | -$40.5M | |
| 2 | -$26.4M | |
| 3 | -$25.4M | |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$16.8M |
| 5 |
Barclays
London,
United Kingdom
|
-$11.6M |